On September 11, 2019 The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) reported a quarterly dividend of forty one cents ($0.41) per share on the $.10 par value Common Stock of the corporation (Press release, Bristol-Myers Squibb, SEP 11, 2019, View Source [SID1234539430]). The next quarterly dividend will be payable on November 1, 2019, to stockholders of record at the close of business on October 4, 2019.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable December 2, 2019 to stockholders of record at the close of business on November 5, 2019.